Evommune Competitors and Similar CompaniesClear all
Evommune's competitors and similar companies include Charles River Laboratories, Gilead Sciences, CanSino Biologics and Athenex.
 Charles River Laboratories Charles River Laboratories International is a company that provides drug discovery and non-clinical development solutions. |  Gilead Sciences Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines. |  CanSino Biologics CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases. |  Athenex Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer. | ||
Founding Date | Founding Date 2020 | Founding Date 1947 | Founding Date 1987 | Founding Date 2009 | Founding Date 2003 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Palo Alto, US HQ | Locations Wilmington, US HQ Melbourne, AU Beerse, BE Brussels, BE São Paulo, BR Laval, CA Saint Constant, CA see more | Locations Foster City, US HQ Buenos Aires, AR Melbourne, AU Wien, AT Machelen, BE São Paulo, BR Edmonton, CA see more | Locations Tianjin, CN HQ | |
Employees | Employees 4521% decrease | Employees 18,3002% decrease | Employees 18,0006% increase | Employees 1,10526% decrease | Employees 575 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 9.6 b | Valuation ($) 110.5 b | Valuation ($) N/A | Valuation ($) 2.3 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $13m (FY, 2025) | Revenue (est.) $4b (FY, 2025) | Revenue (est.) $29.4b (FY, 2025) | Revenue (est.) ¥1.1b (FY, 2025) | Revenue (est.) $102.8m (FY, 2022) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $6.2b (FY, 2025) | Cost of goods ¥81.4m (FY, 2025) | Cost of goods $76.1m (FY, 2022) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $23.2b (FY, 2025) | Gross profit ¥1.1b (FY, 2025) | Gross profit $26.7m (FY, 2022) |
Net income | Net income ($68.9m) (FY, 2025) | Net income ($142.2m) (FY, 2025) | Net income $8.5b (FY, 2025) | Net income ¥27.9m (FY, 2025) | Net income ($104.4m) (FY, 2022) |
Operating ⚠ | |||||
Countries | Countries N/A | Countries 20 (FY, 2021) | Countries 35 (FY, 2021) | Countries N/A | Countries N/A |
Funding | |||||
Total funding raised | Total funding raised $ 57.5m | Total funding raised $ 34m | Total funding raised N/A | Total funding raised $ 76m | Total funding raised $ 252.1m |
For sources of this data, please see the company profile
View Company Profiles
Charles River Laboratories
HQ
Wilmington, US
Employees
18,300↓ 2% decrease
Charles River Laboratories International is a company that provides drug discovery and non-clinical development solutions.
View companyGilead Sciences
HQ
Foster City, US
Employees
18,000↑ 6% increase
Gilead Sciences is a research-based biopharmaceutical company focused on the discovery, development, and commercialization of medicines.
View companyCanSino Biologics
HQ
Tianjin, CN
Employees
1,105↓ 26% decrease
CanSino Biologics (康希诺生物股份公司) is a biopharmaceutical company that provides solutions for the prevention and treatment of infectious diseases.
View companyAthenex
HQ
Buffalo, US
Employees
575
Athenex is a biopharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of cancer.
View company